Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
SJI also recently reported a strong third quarter, and management reiterated its guidance for the rest of 2010. Analysts revised their estimates higher for both 2010 and 2011, sending the stock to a Zacks #2 Rank (Buy) stock.
About SJI
SJI operates several different utilities, its largest being South Jersey Gas Company (SJG). SJG purchases, transmits, and sells natural gas for residential, commercial and industrial use.
Third Quarter Results
SJI reported earnings from continuing operations of 10 cents per share, well above the Zacks Consensus Estimate of 1 cent. SJI lost 6 cents per share in the same quarter in 2009.
Total revenues increased 26.4% year-over-year. This was driven by 46.0% growth in non-utility revenues as the company was the successful bidder to supply retail electricity to over 400 school districts in New Jersey.
The operating margin improved from a razor-thin 0.1% to a slightly less razor-thin 0.3%. This small change led to a 532% increase in operating income.
Outlook
Following the solid quarter, management reiterated its guidance of 5% to 10% growth in earnings per share for 2010.
The Zacks Consensus Estimate for 2010 is $2.65, representing 11% EPS growth over 2009. The 2011 estimate is currently $3.03, equating to 14% EPS growth.
Dividend
South Jersey Industries has a stated goal of achieving at least 6% to 7% growth in the dividend and a payout ratio between 50% and 60%.
Since 2000, the company has raised its dividend at a compound annual growth rate of 6.1%, meeting its goal. It payout ratio is currently 50%, also within the company's target.
A payout ratio between 50% and 60% is typical for a utility company. For instance, Chesapeake Utilities Corp (CPK) has a payout ratio of 49%, Exelon Corp (EXC) is at 54%, and American Electric Power (AEP) pays out 53%.
SJI also recently announced an 11% increase in its dividend to 36.5 cents per share. It has a dividend yield of 2.8%.
Valuation
Shares have risen over 40% in the past 12 months as yield-hungry investors flock to SJI (and other utilities). Valuation has risen a bit too, with shares trading at 19.8x forward earnings, a premium to the industry average of 16.1x. Its price to sales ratio of 1.8 is also higher than its peers at 1.0.
Given the double-digit growth rates expected in 2010 and 2011, however, these premiums appear to be justified.
Todd Bunton is the Growth & Income Stock Strategist for Zacks.com.
Read the full Snapshot Report on SJI